Pillar Invest Corp - 16 May 2023 Form 3/A - Amendment Insider Report for Aceragen, Inc.

Role: 10%+ Owner
Signature: Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
Issuer symbol: N/A
Transactions as of: 16 May 2023
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 19 Jul 2023, 16:05:07 UTC
Date Of Original Report: 23 Jun 2023
Previous filing: 26 Sep 2022
Next filing: 19 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Shares After	Date	Ownership	Footnotes
holding	ACGN	Common Stock	355,247	16 May 2023	By Pillar Partners Foundation, L.P.	F1
holding	ACGN	Common Stock	135,540	16 May 2023	By Pillar Pharmaceuticals 6, L.P.	F1
holding	ACGN	Common Stock	143,747	16 May 2023	By Abude Umari	F1
holding	ACGN	Common Stock	1,547	16 May 2023	By Youssef El Zein	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ACGN	Warrants	16 May 2023	Common Stock	162,601	$0.0100	By Pillar Partners Foundation, L.P.	F1, F2
holding	ACGN	Warrants	16 May 2023	Common Stock	35,687	$0.0100	By Pillar Partners Foundation, L.P.	F1, F2
holding	ACGN	Warrants	16 May 2023	Common Stock	45,114	$0.0100	By Pillar Pharmaceuticals 6, L.P.	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
F2	The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.

Content

Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.

The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.

Remarks:

This Amendment on Form 3/A amends and restates the Form 3 originally filed on June 23, 2023 in its entirety for the sole purpose of excluding 29,965 shares of the Issuer's Common Stock purchased on May 17, 2023 by Mr. Umari, which were previously inadvertently reported in the Form 3 filing and will instead be included in a Form 4 filing.